31 March 2016 : Original article
Liver Transplantation and Donor Body Mass Index >30: Use or Refuse?
Anne AndertABCDEF, Niklas BeckerBC, Florian UlmerB, Wenzel SchöningB, Marc HeinBC, Alexandra RimekBC, Ulf NeumannA, Maximilian SchmedingADEDOI: 10.12659/AOT.896101
Ann Transplant 2016; 21:185-193
Abstract
BACKGROUND: Organ shortage is a major problem in liver transplantation. The use of extended criteria donors has become the most important strategy for increasing the donor pool. However, the role of donor body mass index has not yet been thoroughly investigated. The aim of our study was to compare outcomes after liver transplantation in patients who received a liver from a donor with a BMI <30, 30–39, and ≥40, with special regard to the incidence of early allograft dysfunction (EAD) and primary non-function (PNF).
MATERIAL AND METHODS: One hundred and sixty-three patients who underwent liver transplantation at the University Hospital Aachen between June 2010 and January 2014 were included in this analysis. The outcome of liver transplantation was evaluated by the 30-day and 1-year patient and graft survival rates and the incidences of post-reperfusion syndrome (PRS), EAD, and PNF.
RESULTS: The BMI 30–39 group had a higher incidence of EAD than the BMI <30 and BMI ≥40 groups. We observed 5 cases of PNF in the BMI <30 group. The incidence of acute renal failure was significantly higher in the BMI 30–39 and BMI ≥40 groups than in the BMI <30 group. Patient and graft survival did not differ significantly among the 3 groups.
CONCLUSIONS: Based on the findings of this study, grafts from obese donors with a BMI >30 can be safely transplanted. Therefore, the donor pool can be enlarged to include such obese donors without a negative impact on the long-term patient outcome after liver transplantation.
Keywords: Body Mass Index, Donor Selection, Liver Transplantation
In Press
Original article
Return to Alcohol Use After Liver Transplant: Who Is at Risk?Ann Transplant In Press; DOI: 10.12659/AOT.952998
Most Viewed Current Articles
24 Aug 2021 : Review article 22,489
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
29 Dec 2021 : Original article 18,642
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
29 Sep 2015 : Review article 18,176
Risk Factors for Chronic Renal Insufficiency Following Cardiac TransplantationDOI :10.12659/AOT.893788
Ann Transplant 2015; 20:576-587
22 Nov 2022 : Original article 17,232
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988






